A Product, News and Clinical Update for the Cardiac Catheterization Laboratory Specialist
  ||  Home  ||  Editorial Board  ||  Author Guidelines  ||  Classified Ads  ||  Media Kit  ||  Subscriptions  ||  E-News   ||  Reprints, Rights, Permission and Translation   ||

Cath Lab Digest
Current Issue
Archives
Clinical Events Calendar
Webcasts & Symposia
Classified Ads
Cath Lab News
CME
About Us
Author Guidelines
Search Articles
Editor's Update
Media Kit
Classified & Recruitment Media Kit

Cath Lab Topics
Stents
Cardiac Imaging
Vessel Closure
Pharmacology
Genomics
Embolic Protection
Cath Lab Management

Disease States
Acute Coronary Syndromes
Chronic Total Occlusions
Vulnerable Plaque
Patent Foramen Ovale
Aortic Valve Replacement
Myocardial Infarction
Stroke
Heart Failure
Peripheral Arterial Disease
Peripheral Venous Disease
Cardiac Arrhythmia
Aneurysm
Crosser™ Catheter used Primarily to Treat Proximal LAD Chronic Total Occlusion

Case History A 61-year-old male with no history of infarct, percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG) presented with stable CCS II angina.


Through angiography, a 20 mm chronic total occlusion (CTO) was noted in the proximal to mid left anterior descending (LAD), with retrograde filling from the right coronary artery (RCA) (Figure 1). The patient was hypertensive, had hypercholesterolemia and a positive stress test. The decision was made to attempt to navigate through the LAD CTO with the Crosser Catheter System (FlowCardia, Inc., Sunnyvale, CA) using high frequency mechanical recanalization.


Interventional Procedure
A 6 Fr, XB 3.5 guide catheter was introduced into the left coronary artery and the Crosser catheter was delivered primary to the LAD occlusion over a .014” Asahi Intermediate guide wire (Nagoya, Japan). The Crosser was activated for approximately 2 minutes when the device appeared to be following a subintimal track (Figure 2). After additional device activation, the device was confirmed to be in the true lumen and the bend in the artery gave the appearance of subintimal progress (Figure 3). The Crosser catheter was activated for a total of four minutes, allowing for guide wire placement in the true distal lumen. The Crosser was then withdrawn and a 1.5 mm x 20 mm Maverick® balloon catheter (Boston Scientific, Maple Grove, MN) was used to predilate the recanalized CTO. Subsequently, a 2.5 mm x 20 mm Maverick was used to dilate the lesion and a 3.0 mm x 28 mm CoStar™ paclitaxel stent (Biotronik AG, Berlin, Germany) was delivered for a good final result (Figure 4).

Discussion
In this case, the Crosser catheter proved successful for recanalization of a chronic total occlusion with mid-CTO tortuosity. The case illustrates the ability of the device to navigate a tortuous path of the occlusion within the true lumen without arterial dissection or perforation. The tip of the Crosser catheter mechanically vibrates against the face of the CTO at 20,000 cycles per second (20kHz). This high-frequency, low-amplitude longitudinal stroke provides mechanical impact and cavitational effects, which aid in safe recanalization of an occluded artery. Safe and extremely easy to use, interventionalists may find the “Crosser First” technique more advantageous to avoid dissections often caused by guidewire probing and manipulation at the face of the CTO.

Laura Minarsch can be contacted at euromed@ix.netcom.com


Cath Lab Digest - ISSN: 1073-2667 - Volume 14 - Issue 11 - November 2006 - Pages: 1 - 13

 



The 2005 Cath Lab Digest Salary Survey
Cath Lab Digest conducted its fifth annual salary survey in an attempt to assess the market value of cardiac catheterization laboratory professionals across the country. The survey will also be available on our website, www.cathlabdigest.com, as a PDF file. Cath Lab Digest had 108 survey responses.

Click here to learn more




On Demand Medical Education
CME Activities
Achieving Successful Hemostasis: Prevent RSI Through Mechanical Compression
Evidence-Based Approach to Atrial Fibrillation
TIPS Procedure: Improved Outcomes Through Improved Solutions
more CME activities




About HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP's products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holding LLC, which also owns the North American Center for Continuing Medical Education (NACCME). NACCME provides a wide array of accredited CME offerings with industry thought leaders participating in roundtable meetings, webcasts, symposia, conferences, seminars, podcasts and satellite programs. Discover more about HMP's products and services at www.hmpcommunications.com.


Interventional Cardiology© 2008 HMP Communications | Privacy Policy/Copyright | Contact Us

Your HeartECPNInslime